Rare bone metastases of the olecranon.
Abstract Bone metastases are prevalent in patients with cancer, especially with primary lung, breast, renal cell, thyroid, and prostate carcinomas. When looking specifically at primary renal cell carcinoma, approximately 40% of patients will develop bone metastases during the course of their disease. However, distal bony involvement to the appendicular skeleton occurs less frequently, developing below the elbow and knee in approximately 7% of metastatic renal cell carcinoma patients. The incidence of olecranon metastasis is extremely rare in all cancers and so far only two cases have been reported in literature. We report the third case of an olecranon metastasis in a patient with renal cell carcinoma.
Culleton
Shaelyn
S
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
de Sa
Eric
E
Christakis
Monique
M
Ford
Michael
M
Zbieranowski
Ingrid
I
Sinclair
Emily
E
Cheung
Patrick
P
Campos
Sarah
S
Goh
Philiz
P
Chow
Edward
E
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary*; D002292:Carcinoma, Renal Cell / Q000473:pathology*; D004551:Elbow Joint / Q000473:pathology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods
D000970:Antineoplastic Agents; D007372:Interferons